BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Majbour NK, Aasly JO, Hustad E, Thomas MA, Vaikath NN, Elkum N, van de Berg WDJ, Tokuda T, Mollenhauer B, Berendse HW, El-Agnaf OMA. CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson's disease: a study in LRRK2 mutation carriers. Transl Neurodegener 2020;9:15. [PMID: 32375873 DOI: 10.1186/s40035-020-00192-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Nelson AR. Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer’s Disease. Front Aging Neurosci 2022;14:858429. [DOI: 10.3389/fnagi.2022.858429] [Reference Citation Analysis]
2 Abdi IY, Majbour NK, Willemse EAJ, van de Berg WDJ, Mollenhauer B, Teunissen CE, El-Agnaf OM. Preanalytical Stability of CSF Total and Oligomeric Alpha-Synuclein. Front Aging Neurosci 2021;13:638718. [PMID: 33762924 DOI: 10.3389/fnagi.2021.638718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Constantinides VC, Majbour NK, Paraskevas GP, Abdi I, Safieh-Garabedian B, Stefanis L, El-Agnaf OM, Kapaki E. Cerebrospinal Fluid α-Synuclein Species in Cognitive and Movements Disorders. Brain Sci 2021;11:119. [PMID: 33477387 DOI: 10.3390/brainsci11010119] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Wang P, Luo M, Zhou W, Jin X, Xu Z, Yan S, Li Y, Xu C, Cheng R, Huang Y, Lin X, Yao L, Nie H, Jiang Q. Global Characterization of Peripheral B Cells in Parkinson's Disease by Single-Cell RNA and BCR Sequencing. Front Immunol 2022;13:814239. [PMID: 35250991 DOI: 10.3389/fimmu.2022.814239] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
5 Thaler A, Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Goldstein O, Kestenbaum M, Shirvan JC, Cedarbaum JM, Orr-Urtreger A, Regev K, Shenhar-Tsarfaty S, Mirelman A. Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers. J Parkinsons Dis 2021;11:1285-96. [PMID: 33998549 DOI: 10.3233/JPD-212624] [Reference Citation Analysis]
6 Kwon EH, Tennagels S, Gold R, Gerwert K, Beyer L, Tönges L. Update on CSF Biomarkers in Parkinson's Disease. Biomolecules 2022;12:329. [PMID: 35204829 DOI: 10.3390/biom12020329] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Yin S, Han C, Xia Y, Wan F, Hu J, Kou L, Sun Y, Wu J, Li Y, Zhou Q, Xiong N, Huang J, Wang T. Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A): Could It Be a Promising Biomarker and Therapeutic Target in Parkinson's Disease? Mol Neurobiol 2022;59:1333-44. [PMID: 34984583 DOI: 10.1007/s12035-021-02670-w] [Reference Citation Analysis]
8 Murueta-goyena A, Cipriani R, Carmona-abellán M, Acera M, Ayo N, del Pino R, Tijero B, Fernández T, Gabilondo I, Zallo F, Matute C, Sánchez-pernaute R, Khurana V, Cavaliere F, Capetillo-zarate E, Gómez-esteban JC. Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriers. Parkinsonism & Related Disorders 2022. [DOI: 10.1016/j.parkreldis.2022.01.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kaiserova M, Grambalova Z, Kurcova S, Otruba P, Prikrylova Vranova H, Mensikova K, Kanovsky P. Premotor Parkinson's disease: Overview of clinical symptoms and current diagnostic methods. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2021;165:103-12. [PMID: 33542542 DOI: 10.5507/bp.2021.002] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Zubelzu M, Morera-Herreras T, Irastorza G, Gómez-Esteban JC, Murueta-Goyena A. Plasma and serum alpha-synuclein as a biomarker in Parkinson's disease: A meta-analysis. Parkinsonism Relat Disord 2022;99:107-15. [PMID: 35717321 DOI: 10.1016/j.parkreldis.2022.06.001] [Reference Citation Analysis]
11 Yan Z, Yang W, Wei H, Dean MN, Standaert DG, Cutter GR, Benveniste EN, Qin H. Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson Disease. Neurol Neuroimmunol Neuroinflamm 2021;8:e1036. [PMID: 34301818 DOI: 10.1212/NXI.0000000000001036] [Reference Citation Analysis]